Recorded on July 22, 2021.
PathGen Diagnostik Teknologi disrupts the molecular diagnostics market for cancer through inclusive, robust, and affordable platforms. With a strong ecosystem of academic-business-government-community partnership, PathGen seeks to democratize precision medicine, especially in developing countries, and enable molecular diagnostics for all.
Extreme Tech Challenge Global Finals: Startup Pitches Part 2 – PathGen
From the collection Extreme Tech Challenge Global Finals
April 30
San Francisco, CA
StrictlyVC kicks off the year in SF. Get in the room for unfiltered fireside chats with industry leaders, insider VC insights, and high-value connections that actually move the needle. Tickets are limited.
